Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMNA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $134,712
Award facts
- Contract value 100% obligated
- $134,712.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $134,712.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, was made without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations under this delivery order.
This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, valued at $499,999,999 and awarded on November 13, 2025, authorizes the company to supply a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. As one of multiple regional prime vendor contractors under this initiative, DMS Pharmaceutical Group serves as a critical supplier within the Department of Defense's pharmaceutical supply chain, with the contract extending through December 31, 2036.
Quick answers
Who was awarded contract SPE2DU26FEMNA?
SPE2DU26FEMNA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DU26FEMNA worth?
The government has obligated $134,712 on SPE2DU26FEMNA.
Is contract SPE2DU26FEMNA an order under another contract?
Yes. SPE2DU26FEMNA is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMNA competed?
The extent of competition for SPE2DU26FEMNA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award